Paul Campbell
Comptroller/Controller/Auditor presso VIATRIS INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Posizioni attive di Paul Campbell
Società | Posizione | Inizio | Fine |
---|---|---|---|
VIATRIS INC. | Comptroller/Controller/Auditor | 16/11/2020 | - |
Storia della carriera di Paul Campbell
Precedenti posizioni note di Paul Campbell
Società | Posizione | Inizio | Fine |
---|---|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Comptroller/Controller/Auditor | - | - |
Director of Finance/CFO | - | - |
Statistiche
Distribuzione geografica
Regno Unito | 2 |
Stati Uniti | 2 |
Posizioni
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
VIATRIS INC. | Health Technology |
Aziende private | 1 |
---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Paul Campbell
- Esperienza